Neuro-Oncology Reviews




Volume 27 Number 27
30 September 2025




Home > Publications > Neuro-Oncology Reviews > Volume 27, Year 2025 > Number 27, 30 September






Lohmann P, Schäfer L, Krause S, Altunay B, Willuweit A, Werner JM, Galldiks N, Langen KJ, Mottaghy FM, Lütje S.
Advancements in noninvasive visualization of the immune environment in glioblastoma: A systematic review.
Neurooncol Adv. 2025 Aug 4;7(1):vdaf176. doi: 10.1093/noajnl/vdaf176. PMID: 41019666. Review. ˍ




Qiu J, Zhu F, Quan R, Ye H, Su W, Wang R, Fu Y.
Comparative efficacy and safety of therapeutic strategies for EGFRvIII positive recurrent glioblastoma.
iScience. 2025 Aug 13;28(9):113346. doi: 10.1016/j.isci.2025.113346. PMID: 40917884. Meta-analysis. ˍ




Tamura G, Sugii N, Hirata K, Matsuda M, Ishikawa E.
Single-Dose Intraoperative Perampanel Infusion During Awake Glioma Surgery for Potential Prophylaxis of Intraoperative and Early Postoperative Seizures: A Case Report and Literature Review.
Cureus. 2025 Aug 18;17(8):e90430. doi: 10.7759/cureus.90430. PMID: 40979010. Case report; Review. ˍ




Platten M.
Isocitrate dehydrogenase mutation and microenvironment in gliomas: do immunotherapy approaches matter?
Curr Opin Neurol. 2025 Sep 4. doi: 10.1097/WCO.0000000000001426. PMID: 40916936. Review˰ ˍ




Ho A, Horbinski C, Sachdev S.
Thromboembolism in gliomas: an under-recognized danger.
J Neurooncol. 2025 Sep 5. doi: 10.1007/s11060-025-05204-9. PMID: 40913211. Perspective˰ ˍ




Booth TC, Summers D, Shah J, Bulbeck H, Grant R.
Earlier diagnosis of patients with brain tumour.
Pract Neurol. 2025 Sep 18:pn-2025-004768. doi: 10.1136/pn-2025-004768. PMID: 40967900. Editorial. ˍ








Rana A, Mittal A, Vashist C, Sharma S, Rajput S, Sridhar SB, Malviya R.
Nanoparticle-Based Approaches for Glioblastoma Treatment: Advances and Future Prospects.
CNS Neurol Disord Drug Targets. 2025 Sep 22. doi: 10.2174/0118715273386112250912172648. PMID: 40993928. Review˰ ˍ




Bruno F, Pellerino A, Pronello E, Rudà R.
Rare gliomas: standard treatment approaches and new target therapies.
Curr Opin Neurol. 2025 Sep 25. doi: 10.1097/WCO.0000000000001428. PMID: 40990677. Review˰ ˍ